A Safety Study of GAMMAGARD LIQUID (GGL) in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Clinical trial NCT05363358 · COMPLETED
Trial details
- NCT number
- NCT05363358
- Sponsor
- Takeda
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-05-27
- Primary completion
- 2022-12-01
- Enrollment
- 6086
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.